tiprankstipranks
Trending News
More News >

MedAdvisor Resumes Trading After Court Approval

Story Highlights

MedAdvisor Limited ( (AU:MDR) ) has shared an update.

MedAdvisor Limited has announced that the Federal Court of Australia granted their request to rectify an administrative oversight related to a late lodgement of a cleansing notice for shares issued in a recent placement. Following this court order, MedAdvisor has requested the resumption of trading in its securities, which had been voluntarily suspended. This development is expected to restore normal trading operations and maintain investor confidence.

More about MedAdvisor Limited

MedAdvisor Solutions is a global leader in pharmacy-driven patient engagement solutions, offering personalized experiences to simplify the medication journey. Utilizing the THRiV platform, MedAdvisor enhances pharmacy workflows and patient engagement, serving over 34,000 pharmacies in the US and more than 95% of Australian pharmacies, connecting with over 3.7 million patients.

YTD Price Performance: -56.36%

Average Trading Volume: 634,000

Technical Sentiment Signal: Buy

Current Market Cap: A$57.38M

For detailed information about MDR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App